BANGKOK, May 01, 2025 — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a leading Asian fertility services provider, announced today a reverse stock split at a ratio of 1-for-10. This action consolidates the company’s issued and unissued shares.
Starting May 5, 2025, the company’s Class A Ordinary Shares will trade on the Nasdaq Global Market post-split under the symbol “NIVF” with a new CUSIP number of G0544E121.
The reverse stock split will decrease the number of outstanding Class A Ordinary Shares from 7,302,819 to approximately 730,282. Every ten shares will automatically combine into one. The company will not issue fractional shares; instead, shareholders entitled to a fractional share will receive one full post-split Class A Ordinary Share.
Following the reverse stock split, outstanding options, warrants, and other convertible securities will be adjusted. The number of Class A Ordinary Shares obtainable through these securities will be divided by ten (10), rounded to the nearest whole share, according to the governing agreements.
About NewGen
NewGen provides comprehensive fertility services in Asia, assisting individuals and couples in accessing fertility treatments. Dedicated to expanding access to infertility treatment, NewGen offers complete services, including assisted reproductive technology, egg and sperm donation, and surrogacy where appropriate. The management team has over a decade of combined experience in the fertility sector. Clinics are located in Thailand, Cambodia, and Kyrgyzstan. Further details can be found at . Note that information on NewGen’s website is not part of this press release.
Forward-Looking Statements
This release includes forward-looking statements protected by the U.S. Private Securities Litigation Reform Act of 1995. These statements often use terms like “believe,” “project,” “expect,” and similar expressions to describe future commercial operations, business strategy, and financial condition. These forward-looking statements are predictions based on current expectations and assumptions, thus subject to risks and uncertainties. Various factors, such as the inability to implement business plans, identify opportunities, meet financial projections, or changes in the regulatory or competitive environment, could significantly alter actual outcomes. Refer to the company’s annual report on Form 20-F and other SEC filings for a comprehensive understanding of these risks. These documents are available on the SEC’s website, www.sec.gov. All information is current as of this release date, and the company is not obligated to update these statements unless required by law.
Investor Relations Contact
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email:
“`